In addition, DYRK2 has been reported to be implicated in the suppression of EMT in glioma since it is associated with decreased expression of Vimentin and SNAIL and stabilization of E-cadherin levels [70]. This evidence concerns the gene DYRK2 and central nervous system cancer.